The primary cause of lower back pain is intervertebral disc (IVD) degeneration, with $90 billion spent annually on treatment. Current treatment options are limited and surgical intervention can cause further degradation of the adjacent discs and loss of range of motion. Because of these constraints, tissue engineered IVDs have become an increasing popular research target.
1) develop a method to repair punctured discs and 2) develop a tissue engineered IVD as a possible biological replacement option.
High-density photocrosslinkable collagen gels have been developed in this lab as a means to “plug” a punctured disc and maintain disc height, a metric of disc health.
Our lab has developed a composite tissue engineered IVD made from primary ovine nucleus pulposus (NP) and annulus fibrosis (AF) cells suspended in alginate and collagen respectively. These TE-IVDs have been shown to be effective in an in vivo model, when implanted in the caudal spines of rats. We are now focusing on improving the properties of our discs in vitro using mechanical loading and mesenchymal stem cells.